Typical migraine headaches have been consistently induced by the administration of reserpine to migrainous patients. In such patients an increase in urinary excretion of histidine and lysine has been reported to accompany attacks of migraine (Kimball and Friedman, 1961; Menkes, 1964) . These aminoacids have also been found in the oedema fluid which accumulates near the temporal arteries of patients during attacks of migraine headaches (Wolff, 1963) . These observations suggest that reserpine-induced headaches may be a means of studying migraine. The present study, therefore, was undertaken to test whether the aminoaciduria of spontaneous migraine could be reproduced with reserpine; and to study what relation, if any, exists between the aminoaciduria and the clinical symptoms of migraine headaches.
SUBJECTS AND METHODS
Twenty subjects were studied: seven normal patients; five migrainous patients with spontaneous headaches; and eight migrainous patients with reserpine-induced headaches. The criteria for the diagnosis of migraine were paroxysmal unilateral headaches with or without prodromata, associated nausea, family history, and the absence of other neurological disease. The patients with migraine receiving reserpine were hospitalized in the Metabolic Research Unit of New York University School of Medicine. During the period of study, these hospitalized patients received a standard hospital diet from which were eliminated coffee, tea, and fruits, for purposes of other simultaneously conducted studies (Kimball and Bauer, 1966) . Urine was collected in eighthour fractions daily, and a few granules of thymol and 6 ml. of concentrated HC1 were added to each specimen. Aliquots were stored at -10 to -20°Centigrade.
Each patient served as his own control. Paired urine samples obtained from the same patient during corresponding times of collection were analyzed for histidine concentration. One sample represents the histidine excretion during a headache period following the administration of 2 5 mg. of reserpine (i.m.), the other a control period during which there was no headache or reserpine administration. Histidine is reported as ,ug./mg. creatin- ine. Samples of urine, each of 10 lambda, and histidine standard (125 mg./ml.) were applied in a thin half-inch long horizontal line on Reeve Angel SA-2 ion exchange resin-impregnated paper. The paper was subjected to descending chromatography in a 0-4N acetate buffer (pH 5-1) for four hours. The developed chromatograms were dried in an oven at 60°C. and passed through a solution composed of 0-8 g. ninhydrin and 0-12 g. hydrindantin dissolved in 30 ml. methyl cellusolve and 10 ml. in sodium acetate buffer (pH 5 5) (Moore and Stein, 1954) . The chromatograms were again dried at 60°C. for one hour and left overnight at room temperature for maximal colour development. The paper was cut into strips parallel to the developing chromatogram and mounted in a Photovolt Densicord with a green filter. The concentration of histidine was calculated by integration with a Photovolt Integraph model 49 of the graphically recorded optical densities. With care taken to reduce background density to a minimum, and to preserve a uniform horizontal spot length of j inch, the concentration of histidine expressed as a fraction of the standard was determined with a precision of 5 to 10%.
RESULTS
Increase in urinary histidine was observed following headaches in migrainous patients (Table I) . P values determined by the Student test showed the increase in histidine to be significant (Snedecor, 1956 Effects of reserpine on amino-acid excretion in patients with migraine muscular reserpine on histidine excretion in normal controls is summarized in Table III . In addition to these control patients, in three patients, prolonged fast, hypoglycaemia, and digitalis intoxication were without demonstrable effect on histidine excretion. In migrainous subjects with reserpine-induced headaches, there was a consistent rise in urinary histidine excretion comparable to that associated with spontaneous migraine headaches. In normal subjects, reserpine failed to induce headaches and the effect on histidine excretion was variable and inconsistent. A spontaneous or reserpine-induced headache is consistently associated with elevated histidine excretion, but the converse is not necessarily true. It is thus apparent at once that histidine qua histidine is not involved in producing the migraine attack. There is no suggestion of alteration in histidine metabolism in migrainous patients, but rather the observed histidinuria is interpreted as a signpost of some unexplained derangement. Separation of unidentified substances from urinary lysine may prove to be of more interest than the increase in urinary histidine and may have a more direct bearing on the mechanism of migraine.
It is interesting to note that one subject (P.L.) was considered to have migraine and showed a twofold rise in histidine excretion during spontaneous headache. Administration of 2 5 mg. reserpine failed to induce headache. The Many factors operating during migraine attacks, e.g., emotional response and the influence of adrenal stimulation, have for the purposes of the study been neglected. Whatever the mechanism, it appears reasonable to conclude that the effect of reserpine on histidine excretion in migrainous patients is a real one, and that the data permit, at least for the purpose of further systematic study, a biochemical distinction between migrainous and non-migrainous individuals.
SUMMARY
Twenty patients were studied: seven normals, five with spontaneous migraine, and eight with reserpineinduced headaches. Increases in histidine excretion were found to accompany both spontaneous and reserpine-induced headache. The effect of reserpine on migraine appears to be a useful instrument for biochemical and clinical study. 
